OEI yields 3.81% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, OEI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OEI + JNJ for your $10,000?
OEI targets roughly 90% allocation to large-cap US equities while utilizing an options overlay strategy. Stock selection combines top-down market analysis, evaluating value, quality, and volatility, with bottom-up research on company fundamentals and earnings potential. To enhance income beyond dividends, the fund writes OTM call options on individual stocks, equity indexes, or ETFs. These options are written on 25-75% of the funds equity holdings, with each contract generally covering a specified portion of the underlying assets, and typically expire within one to six months. Additionally, the fund may also purchase OTM put and call options. The calls help retain upside participation, while puts provide downside protection. The strategy seeks to provide a consistent income stream and reduced volatility compared to traditional equity ETFs, though upside potential is capped in strong bull markets due to call-writing. The fund may have a high portfolio turnover rate.
Full OEI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.